Endo Int'l (ENDP) wins appeal to block generic versions of Fortesta - Bloomberg

October 14, 2016 9:41 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Endo Int'l (NASDAQ: ENDP) wins appeal to block generic versions of Fortesta, according o Bloomberg.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Litigation, Trader Talk

Add Your Comment